Nyumbani › Adenoma ya Seluli za Islet › Arizona › Phoenix
Majaribio ya kliniki ya Adenoma ya Seluli za Islet katika Phoenix, AZ
Masomo 4 ya Adenoma ya Seluli za Islet yanatafuta washiriki katika vituo vya Phoenix na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
InaajiriHatua 2/3
- Mayo Clinic Hospital, Phoenix
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
InaajiriHatua 1
- Research Facility, Phoenix
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
InaajiriUtafiti wa uchunguzi
- Mayo Clinic Hospital in Arizona, Phoenix
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
InaajiriHatua 2
- Cancer Center at Saint Joseph's, Phoenix
- Mayo Clinic Hospital in Arizona, Phoenix
Majaribio ya Adenoma ya Seluli za Islet katika miji mingine
- Rochester, MNUtafiti 5
- Los Angeles, CAUtafiti 5
- St. Louis, MOUtafiti 5
- Lexington, KYUtafiti 4
- Columbus, OHUtafiti 4
- Salt Lake City, UTUtafiti 4
- Portland, ORUtafiti 4
- Washington, DCUtafiti 4
- Chicago, ILUtafiti 4
- Jacksonville, FLUtafiti 3
- Irvine, CAUtafiti 3
- Philadelphia, PAUtafiti 3
Masomo mengine katika Phoenix
- Saratani ya MatitiUtafiti 25
- Kansari ya kolorektaliUtafiti 25
- UnenepuUtafiti 22
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 20
- Saratani ya MetastasiUtafiti 20
- Kushindwa kwa MoyoUtafiti 18
- Saratani ya ProstateUtafiti 17
- Saratani (aina zote)Utafiti 17
- Multiple MyelomaUtafiti 16
- Kansari ya PancreasUtafiti 16
- Magonjwa ya Moyo na Mishipa ya DamuUtafiti 16
- Ugonjwa wa AlzheimerUtafiti 15
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.